Skip to main content

Find Clinical Trials

Home
Conditions
RNA Virus Infections

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,843 public trials 821 recruiting studies

Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia

NCT01373281

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +10 more
Locations: Denpasar, Bali, Indonesia

Bandung, West Java, Indonesia

Jakarta, Indonesia

Kuala Lumpur, Malaysia

View Trial Details

Completed

Changing Health Through Food Support (CHEFS) Program

NCT03191253

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Qualitative Evaluation of Tear Fluid and Blood for Auto Antibodies Produced in Response to COVID-19

NCT04542980

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations: Namida Lab Fayetteville, Arkansas, United States

View Trial Details

Completed

Equitable Access to COVID-19 Vaccines

NCT04952376

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations: Mayo Clinic Scottsdale, Arizona, United States

View Trial Details

Completed

COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings

NCT04371835

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, COVID-19, +24 more
Locations: Hospital G de Agudos JM Ramos Mejia Buenos Aires, Buenos Aires F.D., Argentina

Laboratório de Pesquisa Clinica Em Hiv/Aids - Instituto Nacional de Infectologia - Fiocruz Rio de Janeiro, Brazil

Central Hospital of Yaoundé Yaoundé, Cameroon

Cité Verte Hospital Yaoundé, Cameroon

View all 15 locations

View Trial Details

Completed

Development of Childhood Anti-Influenza Immunity

NCT03673345

Conditions: Infections, Influenza, Influenza Immunisation, +6 more
Locations: University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases Rochester, New York, United States

View Trial Details

Completed

Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection

NCT04600141

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations: Fundação São Francisco Xavier Ipatinga, Minas Gerais, Brazil

UNIMED Varginha Varginha, Minas Gerais, Brazil

Universidade Federal de Sergipe Aracaju, Sergipe, Brazil

View Trial Details

Completed

Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19

NCT04486001

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations: Fresno Community Hospital Fresno, California, United States

View Trial Details

Completed

Prevalence of Substance Abuse Among Anti-retroviral Treatment Naive Patients Positive for HIV Antibodies

NCT04847388

Conditions: Blood-Borne Infections, Chemically-Induced Disorders, Communicable Diseases, +14 more
Locations: ART centre, Sadar Hospital Khagaria, Bihar, India

View Trial Details

Completed

TD-0903 for ALI Associated With COVID-19

NCT04402866

Conditions: Acute Lung Injury, Acute Lung Injury (ALI) Associated With COVID-19, COVID-19, +13 more
Locations: Theravance Biopharma Investigational Site Duarte, California, United States

Theravance Biopharma Investigational Site Denver, Colorado, United States

Theravance Biopharma Investigational Site Sebring, Florida, United States

Theravance Biopharma Investigational Site Boston, Massachusetts, United States

View all 24 locations

View Trial Details